Crane NXT, Co.
CXT
$54.58
$2.474.74%
Weiss Ratings | CXT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Good | |||
Risk Index | Fair | |||
Risk Grade | C | |||
Reward Grade | B | |||
Rating Factors | CXT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | Weak | |||
Growth Index | Fair | |||
Efficiency Index | Good | |||
Solvency Index | Excellent | |||
Total Return Index | Weak | |||
Volatility Index | Fair | |||
Beta / Standard Deviation | CXT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Beta | -- | |||
Price History | CXT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 1.64% | |||
30-Day Total Return | -14.77% | |||
60-Day Total Return | -8.52% | |||
90-Day Total Return | 1.14% | |||
Year to Date Total Return | -6.63% | |||
1-Year Total Return | -7.87% | |||
2-Year Total Return | -- | |||
3-Year Total Return | -- | |||
5-Year Total Return | -- | |||
52-Week High % Change | -22.23% | |||
52-Week Low % Change | 0.12% | |||
Price | CXT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $67.01 | |||
52-Week Low Price | $52.05 | |||
52-Week Low Price (Date) | Mar 13, 2025 | |||
52-Week High Price (Date) | Jan 21, 2025 | |||
Valuation | CXT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 2.98B | |||
Enterprise Value | 3.63B | |||
Price/Earnings (TTM) | 16.34 | |||
Earnings Per Share (TTM) | 3.19 | |||
Earnings Per Share Growth | -2.88% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 2.03 | |||
Price/Book (Q) | 2.80 | |||
Enterprise Value/Revenue (TTM) | 2.44 | |||
Price | $54.58 | |||
Enterprise Value/EBITDA (TTM) | 9.73 | |||
Enterprise Value/EBIT | 12.67 | |||
Market Cap Category | Mid Cap | |||
Dividends and Shares | CXT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 57.90M | |||
Dividend Yield | 1.25% | |||
Div. Per Share (Most Recent) | $0.17 | |||
Dividend Per Share (TTM) | $0.65 | |||
Payout Ratio (TTM) | 19.88% | |||
Dividend Per Share (Most Recent) | $0.17 | |||
Company Info | CXT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 781 755 6868 | |||
Address | 950 Winter Street Waltham, MA 02451 | |||
Website | www.cranenxt.com | |||
Country | United States | |||
Year Founded | 2021 | |||
Profitability | CXT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 19.26% | |||
Profit Margin | 12.38% | |||
Management Effectiveness | CXT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 7.93% | |||
Return on Equity | 18.15% | |||
Income Statement | CXT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 1.49B | |||
Total Revenue (TTM) | 1.49B | |||
Revenue Per Share | $25.68 | |||
Gross Profit (TTM) | 665.10M | |||
EBITDA (TTM) | 373.30M | |||
EBIT (TTM) | 286.50M | |||
Net Income (TTM) | 184.10M | |||
Net Income Avl. to Common (TTM) | 184.10M | |||
Total Revenue Growth (Q YOY) | 11.82% | |||
Earnings Growth (Q YOY) | 16.36% | |||
EPS Diluted (TTM) | 3.19 | |||
EPS Diluted Growth (Q YOY) | 15.72% | |||
Balance Sheet | CXT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 165.80M | |||
Cash Per Share (Q) | $2.86 | |||
Total Current Assets (Q) | 642.50M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 1.06B | |||
Current Ratio (Q) | 1.142 | |||
Book Value Per Share (Q) | $18.62 | |||
Total Assets (Q) | 2.39B | |||
Total Current Liabilities (Q) | 562.40M | |||
Total Debt (Q) | 813.90M | |||
Total Liabilities (Q) | 1.32B | |||
Total Common Equity (Q) | 1.06B | |||
Cash Flow | CXT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -318.00M | |||
Cash from Financing (TTM) | 62.10M | |||
Net Change in Cash (TTM) | -53.80M | |||
Levered Free Cash Flow (TTM) | 155.49M | |||
Cash from Operations (TTM) | 214.10M | |||